The Effect of Continuous Treatment with Sodium Nitroprusside on the Serum Kinetics of the Brain Marker Protein S-100β in Neonates Undergoing Corrective Cardiac Surgery by Means of Hypothermic Cardiopulmonary Bypass-Reference-Cited by-同舟云学术

The Effect of Continuous Treatment with Sodium Nitroprusside on the Serum Kinetics of the Brain Marker Protein S-100β in Neonates Undergoing Corrective Cardiac Surgery by Means of Hypothermic Cardiopulmonary Bypass

Published:2000-01-12 Issue:11 Volume:38 Page:
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine
language:
Short-container-title:

Author:

Abdul-Khaliq Hashim,Schubert Stephan,Thomas Fischer Thomas,Böttcher Wolfgang,Harke Cornelia,Alexi-Meskishvili Vladimir,Lange Peter E.,Blasig Ingolf E.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/CCLM.2000.181/pdf

Reference18 articles.

1. Developmental and Neurological Status of Children at 4 Years of Age After Heart Surgery With Hypothermic Circulatory Arrest or Low-Flow Cardiopulmonary Bypass

2. A Comparison of the Perioperative Neurologic Effects of Hypothermic Circulatory Arrest versus Low-Flow Cardiopulmonary Bypass in Infant Heart Surgery

3. Relation of Seizures After Cardiac Surgery in Early Infancy to Neurodevelopmental Outcome

4. Serum S-100 protein levels after pediatriccardiac surgery: A possible new marker for postperfusion cerebral injury

5. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: A clinical and experimental study

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using interleukin-18, Eotaxin-1, and Eotaxin-3 to identify brain injury in neonates with congenital heart disease;Journal of Neuroimmunology;2023-12

2. Cardiopulmonary Bypass and Management;A Practice of Anesthesia for Infants and Children;2019

3. Anesthesia and Sedation for Pediatric Heart Disease;Critical Heart Disease in Infants and Children;2019

4. Neuroprotective Drugs in Infants With Severe Congenital Heart Disease: A Systematic Review;Frontiers in Neurology;2018-07-03

5. Detection of Alpha II-Spectrin Breakdown Products in the Serum of Neonates With Congenital Heart Disease*;Pediatric Critical Care Medicine;2014-03